Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
                
Learn More
Learn More
                                    GAP-43 Antibody (1E3), mFluor Violet 450 SE, Novus Biologicals™
                                    
                                    
                                    
                                    
                                
                            
                            
                            
                            
Mouse Monoclonal Antibody
Supplier: Novus Biologicals NBP192713MFV450
Description
GAP-43 Monoclonal antibody specifically detects GAP-43 in Human, Mouse, Rat samples. It is validated for Western Blot, Immunohistochemistry, Immunocytochemistry/ ImmunofluorescenceSpecifications
| GAP-43 | |
| Monoclonal | |
| mFluor Violet 450 SE | |
| 50mM Sodium Borate | |
| Mouse | |
| Immunogen affinity purified | |
| RUO | |
| Primary | |
| Human, Mouse, Rat | |
| Purified | 
| Western Blot, Immunohistochemistry, Immunocytochemistry | |
| 1E3 | |
| Western Blot, Immunohistochemistry, Immunocytochemistry/ Immunofluorescence | |
| Axonal membrane protein GAP-43, B-50, calmodulin-binding protein P-57, growth associated protein 43, Growth-associated protein 43, nerve growth-related peptide GAP43, Neural phosphoprotein B-50, neuromodulin, neuron growth-associated protein 43, PP46, protein F1 | |
| C-terminal peptide of rat and mouse GAP43 (KEDPEADQEHA) to which an N-terminal Cysteine residue was added to allow chemical coupling to Keyhole Limpet Hemocyanin carrier protein. | |
| 0.1 mL | |
| Cancer, Cellular Markers, Growth and Development, Neuronal Cell Markers, Neuroscience, Phospho Specific | |
| 2596 | |
| Store at 4C in the dark. | |
| IgG1 | 
                    Product Content Correction
                
                Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
			
            Spot an opportunity for improvement?Share a Content Correction